Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

SHA:603139 Revenue

Shaanxi Kanghui Pharmaceutical had revenue of 93.36M CNY in the quarter ending March 31, 2026, a decrease of -23.07%. This brings the company's revenue in the last twelve months to 443.29M, down -20.22% year-over-year. In the year 2025, Shaanxi Kanghui Pharmaceutical had annual revenue of 471.29M, down -16.09%.

• Revenue (ttm): 443.29M
• Revenue Growth: -20.22%
• P/S Ratio: 9.36
• Revenue / Employee: 551.36K
• Employees: 804
• Market Cap: 4.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	471.29M	-90.35M	-16.09%
Dec 31, 2024	561.63M	-111.33M	-16.54%
Dec 31, 2023	672.96M	181.45M	36.92%
Dec 31, 2022	491.51M	48.75M	11.01%
Dec 31, 2021	442.76M	28.69M	6.93%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error